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Tityusserrulatusscorpionvenom(TSV)consistsofaverycomplexmixtureofmoleculesanddemonstratessigniﬁcantimmunomod-
ulatory activities capable of stimulating immune functions in vivo. The purpose of this study was to compare the crude TSV with
fractionated toxins extracted from this venom in order to determine which toxin(s) presented immunomodulatory eﬀects on peri-
toneal macrophages. TSV was fractionated using gel ﬁltration chromatography resulting in 5 heterogeneous fractions. The eﬀects of
these diﬀerent fractions were analysed in vitro using detection by means of cytokines, oxygen intermediate metabolites (H2O2), and
nitric oxide (NO) in supernatants of peritoneal macrophages. Several functional bioassays were employed: tumor necrosis factor
(TNF) activity was assayed by measuring its cytotoxic activity in L929 cells, and other cytokines were assayed by enzyme-linked
immunosorbent assay, whereas NO levels were detected by Griess colorimetric reactions in culture supernatant of macrophages
e x p o s e dt od i ﬀerent fractions. In vitro studies revealed that all fractions studied here presented an increment in H2O2, NO, and
cytokines levels. The more pronounced increments were observed in macrophage cultures exposed to fraction FII which demon-
strated that (a) the highest levels of IL-1α,I L - β, and TNF were observed after 12 hours and that (b) the maximum levels of IFN-γ
andNOwereobservedafter72hours.Takentogether,thesedataindicatethatfractionshaveadiﬀerentialimmunomodulatingeﬀect
on macrophage secretion, and that FII is a potent activator of TNF production of macrophages.
INTRODUCTION
Scorpion venoms consist of a complex of several tox-
ins that exhibit a wide range of biological properties and
actions, as well as chemical compositions, toxicity, and
pharmacokinetic and pharmacodynamic characteristics.
Tityus serrulatus is considered one of the most dan-
gerous species to humans in Brazil and is responsible for
many clinical cases of envenomation in the southern re-
gion of this country. This venom is capable of exerting
av a r i e t yo fe ﬀects on excitable tissues, due to its role in
the peripheral nervous system where it enhances the re-
leaseofneurotransmitters [1]. Theinformation presented
here deals with biological, chemical, and immunological
aspects of diﬀerent toxins and oﬀers a comparison and
an assessment of these, as observed in the symptoms pre-
sented in mice from the most dangerous species of Brazil-
ian scorpions: Tse rru l a t u s .T h i ss p e c i e si sf o u n di na ni m -
mense geographical area of the country and represents an
important public health problem causing fatal accidents
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among humans [2, 3]. The most thoroughly studied as-
pects consist of the isolation, chemical, and physiological
characterization of these toxic peptides [4, 5, 6].
Victims of envenoming by a scorpion suﬀer a va-
riety of pathologies, involving mainly both sympathetic
(tachycardia, hypertension, sweating, and mydriasis) and
parasympathetic (bradycardia, hypotension, secretions,
and miosis) stimulation as well as central manifestations
such as irritability, hyperthermia, vomiting, tremor, and
convulsion. Experimental studies have shown that the
injection of whole venom and puriﬁed toxins from the
venom Ts e r r u l a t u scan cause profuse salivation [7], in-
creased gastric [8] and pancreatic secretion [9], acute gas-
tric mucosal [10] and pancreatic [1, 9] injuries, as wells
as disorders in intestinal motility [1]. In order to address
these issues, basic information needs to be obtained from
representative experiments on animal models using ade-
quate venom samples as it is necessary to apply inﬂam-
matory inducers. Previous studies have shown that dif-
ferential susceptibility to venom depends on the strain of
mice used [11, 12]. It is well established that the predom-
inant lethal action of scorpion venom exerts a variety of
eﬀects on excitable tissues. In the case of snake venoms, it
is well known that levels of lethality and toxicity exhibit
enormous variety according to the age, sex, nutritional40 V. L. Petricevich and I. Lebrun 2005:1 (2005)
state,andgeographic regions wherethe animals werecap-
tured [13]. To minimise the experimental bias, BALB/c
mice and a mixture of Ts e r r u l a t u svenom obtained from
40 adult specimens, all from the same geographic region,
were used throughout all experiments.
Macrophages have been shown to be involved
in diﬀerent homeostatic mechanisms and pathological
events, and may be engaged in complex interactions.
Macrophages are involved in several areas of body func-
tion, such as phagocytosis, enzyme liberation, free radical
generation, and as mediators of inﬂammatory processes.
Cytokinereleasebymacrophageshasshownthatexcessive
or insuﬃcient production may signiﬁcantly contribute to
the pathophysiology of a range of diseases [14, 15, 16, 17].
Generally, the treatment of macrophages with lead re-
sults in the disregulation of the production of inﬂamma-
tory cytokines, tumor necrosis factor (TNF), interleukin-
1 (IL-1), and IL-6, and preferential production of the
TH1 type of cytokines interferon-gamma (IFN-γ)a n dI L -
2. In the case of crude scorpion venom, the treatment
of macrophages results in the production of inﬂamma-
tory cytokines [18]. It is widely acknowledged that in cy-
tokines, a diverse group of proteins are important for the
regulation of inﬂammatory responses as well as in the
generation of immunity to pathogens. Interaction with
venom causes the secretion of a variety of cytokines by
macrophages. However a detailed description of the in-
duction of these cytokines by venoms is still unclear even
though various studies regarding cytokine induction by
these toxins as well as by infection have been reported
[18, 19].
TSV is involved in immunomodulation, although the
mechanism for this activity has not been fully elucidated.
This study was designed to determine the most impor-
tant toxin obtained from venom which causes the im-
munomodulatory activity. Here for the ﬁrst time we de-
scribed in detail the eﬀect of puriﬁed fractions extracted
from TSV on the production of cytokines and nitric ox-
ide (NO) production and on macrophage activation. Im-
munomodulatory eﬀects induced by these fractions on
NO production and macrophage activation were com-
pared with those obtained from the cells stimulated with
IFN-γ.
MATERIALS AND METHODS
Chemicals,reagents,andbuffers
Actinomycin D, orthophenyldiamine (OPD), and ni-
tric oxide (NO) were purchased from Sigma (St. Louis,
Mo),fetalcalfserum(FCS)andRPMI-1640mediumwere
purchasedfromCultilab(Campinas,SP,Brazil),Sephadex
G-50 Superﬁne was purchased from Pharmacia Fine
Chemicals (Uppsala, Sweden), ANTI-mouse-IL-1 (clones
ALF-1G1 and B122), recombinant IL-1, ANTI-mouse-
IL-6 (clones MP5-20F3 and MP5-32C11), recombinant
IL-6, ANTI-mouse-IFN-γ (clones XGM1.2 and R4-6A2)
and recombinant IFN-γ were purchased from BD Bio-
sciences Pharmingen (Calif), and recombinant TNF was
purchasedfromBoehringerMannheim(Mannheim,Ger-
many).
Scorpionvenom
Ts e r r u l a t u sscorpions were provided by the
Artropodes Laboratory, Butantan Institute (SP, Brazil).
The venom was obtained by electrostimulation using
the method previously described [20]. Fifty mg of crude
driedvenomwassolubilizedinammoniumacetatebuﬀer,
pH 4.7, and centrifuged at 15000Xg for 30 minutes, here
named TSV(—), without glycoproteins, and fraction G
was named the nontoxic fraction. Soluble venom from T
serrulatus was applied to a Sephadex G-50 Superﬁne and
eluted with 20mM ammonium acetate buﬀer, pH 4.7.
The fractions were collected using an automatic collector
(Pharmacia-LKB Frac-100). Fractions were pooled ac-
cording to the absorbance proﬁle at 280nm and assayed
for toxicity. The ﬁve fractions obtained here are named as
fractions FI, FII, FIII, FIV, and FV which correspond to
18.6%, 31.4%, 21.3%, 24.4%, and 4.3%, respectively.
Animals
BALB/c female mice (18–20g), obtained from the Bu-
tantan Institute, were used throughout the study to test
the lethality of the venom and its components. Diﬀerent
fractions containing 50µg of protein diluted in the ap-
propriate buﬀers were assayed by intraperitoneal (IP) in-
jection. Intoxicated animals usually showed the following
symptoms: tremor, salivation, diarrhoea, and death. Mice
weremaintainedandusedaccordingtoanimalwelfarein-
ternational recommendations of the International Society
on Toxicology, 1992 [21].
Stimulationofmiceperitonealmacrophages
Groups of mice from BALB/c were sacriﬁced and
their cells were harvested by peritoneal lavage [22]. The
peritoneal cavity was injected with 5mL of cold RPMI-
1640.Theﬂuid-distendedperitonealcavitywasmassaged,
and the cells were collected and washed three times by
centrifugation at 290Xg for 5 minutes. The cells were
seeded in 96-well microtiter plates at a concentration of
1 × 106cells/mL and cultured in RPMI-1640 medium
supplemented with 10% FCS. After incubation at 37◦C
for 2 hours in humidiﬁed 5% CO2, the plates were then
washed twice with RPMI-1640 medium to remove non-
adherent cells and the adherent cells were referred to as
macrophages. More than 95% of the cells was identiﬁed
as macrophages by morphology and also in terms of their
ability of ingesting IgG-opsonised red cells [23]. These
c e l l sw e r ee x p o s e dt od i ﬀerent concentrations of fractions
obtainedfromTSVvenominRPMI-1640containing10%
FCS.Afterincubationat37◦Cforvariousintervalsoftime
in a humidiﬁed atmosphere of 5% CO2, the supernatants
were collected and stored at −20◦C until assayed for the
presence of NO and cytokines.2005:1 (2005) Immunomodulatory Eﬀects of the Ts e r r u l a t u sVenom 41
H2O2 determination
Peritoneal macrophages were obtained as described
previously where 1 × 106 cells/mL was seeded and
incubated in a volume of 100µL with no stimuli (con-
trol), or were exposed to recombinant IFN-γ (10ng/mL)
or fractions obtained from TSV of varying amounts
(µg/mL). After incubation at 37◦C for various intervals
of time in a humidiﬁed atmosphere of 5% CO2, the su-
pernatants were then collected for NO determination and
100µL of red phenol solution containing 140mM NaCl,
10mMK2PO4,5.5mMdextrose,and5.5mMhorseradish
peroxidase were added to the adherent cells for H2O2 de-
termination. After incubation for 1 hour at 37◦C, 10µL
of 1M NaOH were added and the absorbances were mea-
sured at 620nm, using an automatic enzyme immunoas-
say reader [24].
NOdetermination
The levels of NO in supernatants taken from
macrophage controls or exposed to fractions FI, FII, FIII,
FIV, FV obtained from TSV or IFN-γ were assayed by
adding 100µL of freshly prepared Griess reagent [25]t o
100µL of the sample in 96-well plates, and then read-
ing the absorbance at 540nm after 10 minutes. Later they
were compared with the absorbance curves of serial dilu-
tions of sodium nitrate in complete culture medium. The
minimum level of NO which was detected under the assay
conditions was 1nmol.
Cytokinedetermination
The levels of cytokines IL-1, IL-6, IFN-γ in the cul-
ture supernatants were assayed using a two-site sand-
wich enzyme-linked immunosorbent assay (ELISA) [26].
In brief, ELISA plates were coated with 100µL( 1µg/mL)
ofthemonoclonalantibodiesanti-IL-1α,anti-IL-1β,anti-
IL-6,oranti-IFN-γ in0.1Msodiumcarbonatebuﬀer(pH
8.2) and incubated for 6 hours at room temperature. The
wells were then washed with 0.1% phosphate-buﬀered
saline (PBS/Tween-20) and blocked with 100µL of 10%
FCS in PBS for 2 hours at room temperature. After wash-
ing,duplicatesupernatantmacrophageculturesamplesof
50µL were added to each well. After 18 hours of incu-
bation at 4◦C, the wells were washed and incubated with
100µL(2µg/mL)ofthebiotinylatedmonoclonalantibod-
ies anti-IL-α, anti-IL-1β, anti-IL-6, or anti-IFN-γ as sec-
ond antibodies for 45 minutes at room temperature. Af-
ter a ﬁnal wash, the reaction was developed by the ad-
dition of OPD to each well. Optical densities were mea-
sured at 405nm in a microplate reader. The cytokine con-
tent of each sample was read from a standard curve es-
tablished with the appropriate recombinant cytokine (ex-
pressed in ng/mL). The minimum levels of each cytokine
detectable in the conditions of the assays were 0.78, 2.9,
and 0.05ng/mL for IL-6, IFN-γ,a n dI L - 1 ,r e s p e c t i v e l y .
To measure the cytotoxicity of TNF present in the su-
pernatants taken from the macrophages, a standard assay
with L929 cells, a ﬁbroblast continuous cell line, was used
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Figure 1. Puriﬁcation of TSV. Fifty mg of TSV was extracted
with 2mL of ammonium bicarbonate solution 20mM, and
46mg of the soluble venom was applied to Sephadex G-50 col-
umn (80cm × 0.4cm) and eluted with 20mM ammonium bi-
carbonate solution, pH 7.4. The fractions were collected using
an automatic collector and pooled according to the absorbance
proﬁle at 280nm and assayed for toxicity.
as described previously by Ruﬀ and Giﬀord [27]. The cy-
totoxicity percentage was calculated as follows: (Acontrol −
Asample/Acontrol) ×100.
Statisticalanalyses
Data are expressed as the mean ± standard deviation.
StatisticalanalyseswereperformedbyStudent“t test” and
the level of signiﬁcance was set at P<. 005.
RESULTS
Chromatography
The TSV venom was puriﬁed by gel ﬁltration chro-
matography. Figure 1 shows the chromatography proﬁles
of components from the venom of Ts e r r u l a t u s . The frac-
tions FII, FIII, and FIV represent the most abundant tox-
ins of TSV, corresponding to 31.4%, 21.3%, and 24.4%
of the whole soluble venom. PAGE conﬁrmed the homo-
geneity of this component (results not shown). All frac-
tions obtained were tested on mice and macrophage cul-
tures.
Lethal,toxic,ornontoxicdosesvariations
Symptoms. Victims of scorpion envenoming suﬀer
a variety of pathologies such as irritability, hyperther-
mia, vomiting, tremor, and convulsion. To determine the
symptoms, groups of BALB/c female mice weighing be-
tween 18–20g were IP injected with diﬀerent doses of
the fractions and were observed at various time inter-
vals (results not shown). Three designations were used
to characterize the degree of intoxication: “lethal” mean-
ing that the animal showed some, if not all, of the symp-
toms described and died within 24 hours after injection.
When FII and/or FIII were applied at a concentration cor-
responding to 105µg, they had a lethal eﬀect on mice.
In contrast, these same fractions applied at a concen-
tration of 50µg for the assay per mouse demonstrated42 V. L. Petricevich and I. Lebrun 2005:1 (2005)
Tremor
50µg3 0 µg
40µg
15 30 45 60 90 120 150 180 210 240
Time after injection (min)
0
25
50
75
N
u
m
b
e
r
o
f
a
n
i
m
a
l
s
(
%
)
Tremor
50µg3 0 µg
40µg
15 30 45 60 90 120 150 180 210 240
Time after injection (min)
0
50
100
N
u
m
b
e
r
o
f
a
n
i
m
a
l
s
(
%
)
Diarrhoea
50µg3 0 µg
40µg
15 30 45 60 90 120 150 180 210 240
Time after injection (min)
0
25
50
75
N
u
m
b
e
r
o
f
a
n
i
m
a
l
s
(
%
)
Diarrhoea
50µg3 0 µg
40µg
15 30 45 60 90 120 150 180 210 240
Time after injection (min)
0
25
50
75
100
N
u
m
b
e
r
o
f
a
n
i
m
a
l
s
(
%
)
Salivation
50µg3 0 µg
40µg
15 30 45 60 90 120 150 180 210 240
Time after injection (min)
0
25
50
75
N
u
m
b
e
r
o
f
a
n
i
m
a
l
s
(
%
)
(a) Fraction FII.
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(b) Fraction FIII.
Figure 2. Symptoms. Groups of female mice from the BALB/c strain, 18–20g of body weight, were injected IP with diﬀerent doses
of fractions (FII or FIII). At diﬀerent time intervals, the speciﬁc signs were observed. Each point represents the percentage number of
animals with symptoms.
at o x i ce ﬀect. “Toxic” means that the mouse showed
some of the symptoms described but survived (Figure 2).
The FI, FIV, and FV applied at a concentration of 50µg
for the assay per mouse showed nontoxic eﬀects, mean-
ing that the mouse demonstrated the same behaviour
as after injection with saline solution (data not shown).
Tremor started to appear in some animals 60 and 30
minutes after injection with FII and FIII, respectively.2005:1 (2005) Immunomodulatory Eﬀects of the Ts e r r u l a t u sVenom 43
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Figure 3. H2O2 and NO production. Peritoneal macrophages were obtained and stimulated in vitro with 50µg of each fraction
obtained from TSV, as described in “materials and methods.” The activation of the cultured peritoneal macrophages was determined
by measuring the oxygen intermediate metabolites (H2O2). NO levels were detected by the Griess colorimetric reaction. Each point
represents the mean ± standard deviation value of samples from ﬁve experiments carried out on diﬀerent groups each consisting of
ﬁve mice. Statistical diﬀerences between the treatments were (P>. 001).
In groups of mice injected with FII, diarrhoea started to
appear in some animals between 60–90 minutes after in-
jection with 40 and/or 50µg per mouse, respectively (Fig-
ure 2). In contrast, in groups of mice injected with 30, 40,
or 50µg/mouse of FIII, these symptoms were observed 30
minutes after injection (Figure 2). With respect to sali-
vation, this symptom appeared 60 minutes after injec-
tion and progressed for 150 minutes after injection with
50µg/mouse of FII (Figure 2). Salivation was also ob-
servedingroupsofanimalsinjectedwith30,40,and50µg
of FIII (Figure 2).
EffectoffractionsfromTSVoninvitroH2O2,
NO,andcytokineproduction
To determine cytokine production, groups of mice
were sacriﬁced and the macrophages, which were col-
lected by peritoneal lavage, were exposed in vitro to vary-
ingamountsofdiﬀerentfractionsobtainedfromTSV.The
ﬁrst issue to be addressed was the determination of the
amounts of diﬀerent fractions obtained from TSV. For
this purpose, four diﬀerent concentrations, ranging be-
tween 25–150µg of the various fractions were used (re-
sultsnotshown).Allfractionswerecapableofstimulating
cytokine, NO and H2O2 production, in a way which was
dose-dependent (results not shown). Thus, in subsequent
cell experiments, 50µg was used since this concentration
was eﬃcient for all fractions.
T h el e v e l so fH 2O2 observed in macrophages groups
stimulated for 48 hours with FII and FIII were similar
to those observed for TSV(—) (Figure 3a). The levels of
NO in groups of macrophages exposed to FII were signif-
icantly higher when compared with those obtained from
cultures exposed to TSV(—) and/or other fractions (P>
.001) (Figure 3b). Interestingly the nontoxic fractions had
signiﬁcantlylowerlevelsofH2O2 andNOwhencompared
to those obtained from FII, FIII, and/or TSV(—) (Figures
3a and 3b).
T h ei nv i t r oe x p o s u r eo fm a c r o p h a g e st oF I Ir e -
sulted in the production of higher levels of IL-1α
(Figure 4). Similar levels ofIL-1β wereobserved in groups
of macrophages exposed to FII, FIII, FV, and TSV(—)
(Figure 4). The highest levels of IL-6 were observed in
groups of macrophages exposed in vitro to TSV(—) or
FII were observed (P>. 001) (Figure 4). The high lev-
els of IFN-γ in groups of macrophages exposed in vitro
to TSV(—), FII, and FV were observed (Figure 4). Inter-
estingly, only macrophages groups exposed to FII demon-
strated TNF production (Figure 4).
KineticsofH2O2,NO,andcytokineproduction
To determine the kinetics of H2O2, NO, and cy-
tokine production, groups of mice were sacriﬁced and
the macrophages, which were collected by peritoneal
lavage, were exposed in vitro to 50µgo fe a c hf r a c t i o n
obtained. The in vitro exposition of macrophages to FII,
FIII, or TSV(—) resulted in H2O2 production (Figure 5).
The maximum production of H2O2 was detected in cul-
tures stimulated for 48 hours, decreasing thereafter (Fig-
ure 5). Similar levels of H2O2 were observed in groups
of macrophages stimulated in vitro with FII, FIII, or
TSV(—) (Figure 5).
T h el e v e l so fN Oi n c r e a s e df o ru pt o7 2h o u r sf o r
all macrophage groups exposed in vitro to FII, FIII, or
TSV(—) decreasing thereafter (Figure 5). The levels of
NO in groups of macrophages stimulated with FII were
signiﬁcantly higher when compared with those obtained
from FIII and TSV(—) cultures (P>. 001) (Figure 5).
We noted a signiﬁcant diﬀerence in IL-1 production
between fractions obtained from TSV (Figure 6). The
maximum levels of IL-1α and IL-1β were observed in cul-
tures stimulated for 12 hours (Figure 6). The levels of IL-
1αingroupsofmacrophagesstimulatedwithFIIweresig-
niﬁcantly higher when compared with those obtained in
FIII and TSV(—) cultures (P>. 001) (Figure 6). Twelve
hours after treatment, macrophages exposed to FII se-
c r e t e dt w i c ea sm u c hI L - 1 α compared to macrophages
infected with TSV(—) or FIII (P>. 001). With respect
to IL-1β production similar levels were observed among44 V. L. Petricevich and I. Lebrun 2005:1 (2005)
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Figure 4. Cytokine released by peritoneal macrophages from BALB/c mice. Peritoneal macrophages were obtained and stimulated
in vitro with 50µg of the various fractions obtained from TSV, as described in “materials and methods.” The levels of IL-1 were
determined after 12 hours, for IL-6 after 24 hours and for IFN-γ after 72 hours. They were assayed by ELISA assay using antibodies as
the probe. TNF levels were determined by a standard assay with L929 cells. Each point represents the mean value of samples from ﬁve
experiments ± standard deviation among diﬀerent groups consisting of ﬁve mice. Statistical diﬀerences between the treatments were
(P>. 001).
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Figure 5. The kinetic of activation and NO production. Peritoneal macrophages were obtained and stimulated in vitro with 50µgo f
FII, FIII, and TSV(—) obtained as described in “materials and methods.” The activation of peritoneal macrophages was determined
by measuring the oxygen intermediate metabolites (H2O2). NO levels were detected by the Griess colorimetric reaction. Each point
representsthe mean ±standard deviation valueofsamples fromﬁveexperimentsin diﬀerentgroupsconsistingof ﬁvemice.Statistical
diﬀerences between the treatments were (P>. 001).
all groups of macrophages that were stimulated (Figure
6). As shown in Figure 6, the maximum levels of IL-
6 were observed in all cultures stimulated for 24 hours.
T h el e v e l so fI L - 6i ng r o u p so fm a c r o p h a g e se x p o s e dt o
FII and TSV(—) were signiﬁcantly higher when com-
pared with those obtained in FIII cultures (P>. 001)2005:1 (2005) Immunomodulatory Eﬀects of the Ts e r r u l a t u sVenom 45
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Figure 6. The kinetic of cytokines released by peritoneal macrophages from BALB/c mice. Peritoneal macrophages were obtained and
stimulated in vitro with 50µg of TSV(—), FII, and FIII obtained from TSV as described in “materials and methods.” IL-1, IL-6, and
IFN-γ were assayed by ELISA assay using antibodies as the probe. TNF levels were determined by a standard assay with L929 cells.
Each point represents the mean value of samples from ﬁve experiments ± standard deviation in diﬀerent groups consisting of ﬁve
mice. Statistical diﬀerences between the treatments were (P>. 001).
(Figure 6). For groups of macrophages exposed to FII and
TSV(—) levels of IFN-γ started to appear after 12 hours
for all groups, increasing for up to 72 hours and de-
creasing thereafter. In the case of groups of macrophages
exposed to FII and TSV(—). In the case the groups of
macrophages stimulated with FIII, the high levels of IFN-
γ were observed after 48 hours (Figure 6). Under the con-
ditions used in this study, TNF production from murine
peritoneal macrophages was not observed after treatment
with TSV(—) and FIII. In contrast, high levels of TNF46 V. L. Petricevich and I. Lebrun 2005:1 (2005)
were observed for groups of macrophages exposed to FII
for 12 hours (Figure 6).
Effectofexogenouscytokineonmacrophages
stimulatedwithFII,FIII,orTSV(—)
Toverifywhetherexogenouscytokines,suchasIFN-γ,
showed an eﬀect on macrophages treated with TSV(—),
FII, or FIII, the levels of H2O2 and NO were determined.
TheadditionofIFN-γ totheculturemediumdidnotalter
H2O2 released by the fractions or the TSV(—)-activated
macrophages. In contrast, the addition of IFN-γ to the
culture medium signiﬁcantly altered the amount of sig-
niﬁcance (P>. 01), NO secretion by the FII-activated
macrophages (Figure 7).
DISCUSSION
Scorpion venom consists of complex mixtures of sev-
eral toxins that exhibit various biological activities. It has
already been shown that human victims stung by scor-
pion or experimentally injected animals may exhibit signs
and symptoms which involve the central nervous system,
stimulation of the autonomic system, and, occasionally,
respiratoryandheartfailure,andevendeath[28,29].Var-
iousfactorscancontributetothemanifestationofspeciﬁc
signs and symptoms as reactions to stings with respect the
scorpion venom toxicity which may vary [30]. However
it has been demonstrated that other factors may also be
considered as clinical signs such as the age or size of the
victims, for example, children are normally more severely
aﬀected, the site of the injection, and the individual’s vul-
nerability to venom [28, 29, 31].
Data presented in this report reveal the immunomod-
ulating property of TSV: (1) the induction of cytokines by
peritoneal macrophages and (2) the induction of NO se-
cretion and enhancement of H2O2. The experiments were
designed in order to know which fraction is responsible
for the immunomodulating eﬀect; and subsequently sev-
eral strategies for applying injections were tested. With
respect to the speciﬁc signals, the dose administered, the
severity of envenoming, and the cytokines and NO pro-
duction were studied and discussed.
The rapid absorption and distribution of scorpion
venom toxins indicate that scorpion envenoming is an ex-
treme emergency case. Speciﬁc signs and symptoms are
usually manifested very soon after envenomating, and de-
velop into systemic inﬂammatory manifestations and or-
gan failure. Increasing evidence from animal studies as
well as clinical experience show that the involvement of
the inﬂammatory cascade and release of cytokines play a
major role in the pathogenesis of many envenoming syn-
dromes.
The quality of the immune response is reﬂected in the
production of immunoglobulin isotypes, the diﬀerent T-
cell subsets activated, and the cytokines synthesized. The
characterization of the roles of speciﬁc cytokines gener-
ated during an immune response has been impeded be-
cause of the complexity of the cytokine system, not only
because of the pleiotropic eﬀects of individual cytokines
but also because of antagonistic and synergistic eﬀects of
cytokine combinations.
Severe envenomating induced in mice injected with
TSV was associated with an elevation in the serum lev-
els of various cytokines and NO. With respect to im-
mune response, recent studies regarding the roles that cy-
tokines may play in defending the host also indicate the
importance of this aspect in the case of envenomating.
Cytokines are a group of regulatory and immunomodu-
latory proteins involved in a number of physiological pro-
cesses. As part of the characterization of the hosts reactiv-
ity to TSV(—) and/or fractions, inﬂammatory responses
in the mouse model were investigated. Proinﬂammatory
cytokines induce local and systemic inﬂammatory mani-
festations. The local eﬀects include the activation of vas-
cular endothelium, an increase in vascular permeability,
and access of leukocytes to the aﬀected tissue and their
activationandlocaltissuedestruction.Thesystemicman-
ifestationsincludefever,theacute-phaseresponse,andin-
duction of a systemic shock in severe inﬂammatory pro-
cesses. The proinﬂammatory cytokines such as IL-1, TNF,
and IL-6 are endogenous pyrogens, which raise the body
temperature in a way which is believed to help eliminate
infections[32,33].Thus,IL-1probablycontributestosys-
temic inﬂammatory response in envenomated mice.
The cytokine IL-1 mainly aﬀects inﬂammatory pro-
cesses but also possesses various immune, degradative,
and growth-promoting properties. There are two IL-1
agonistic proteins, IL-1α and IL-1β, and one antago-
nistic protein [34]. IL-1α and IL-1β bind to the same
receptors, and there are no signiﬁcant diﬀerences in their
spectrum of activities [34]. However, the processes of
IL-1α and IL-1β diﬀer: IL-1β is active only as a secreted
mature product, whereas IL-1α is active as a precur-
sor or membrane-associated molecule. IL-1α remains
cytosolic but IL-1β is abundantly secreted by activated
macrophages and blood monocytes. Here, we show that
IL-1β production was observed among all macrophages
exposed to fractions obtained from TSV. The maximum
production of IL-1α was observed in cultures exposed to
FII for 12 hours. In this study, TSV(—) and its fractions
induced elevations of IL-1α and IL-1β,w h i c hw e r e
detected by ELISA. The eﬀect of IL-1 production in
response to TSV stimulation in vitro may be a double-
edged sword. The results presented here demonstrate that
IL-1maycontributetothesymptoms ofvenomtreatment
by emphasizing the eﬀect of other cytokines. Apparently
the biological actions appear to contribute to the shock
induction and other systemic alterations.
Other studies have shown that inﬂammatory mod-
els have indicated that proinﬂammatory substances and
some cytokines were deeply involved in the activation of
endothelial cells and leukocytes [35]. The results obtained
in this study showed the eﬀect of TSV(—) and its frac-
tions on murine peritoneal macrophages. These results
are in accordance with previous studies that showed an2005:1 (2005) Immunomodulatory Eﬀects of the Ts e r r u l a t u sVenom 47
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Figure 7. Comparisons of H2O2 and NO production after FII,
FIII, TSV(—), or IFN-γ stimulation. Groups of mice were sac-
riﬁced and their peritoneal macrophages were collected. Peri-
toneal macrophages were stimulated in vitro with 50µg/mL of
FII, FIII, TSV(—), IFN-γ (10ng/mL), FII + IFN-γ,F I I I+I F N -
γ, or TSV(—) + IFN-γ.H 2O2 and NO levels were determined
as described in Figure 5, at 48 and 72 hours after stimulation,
respectively. Each point represents the mean ± standard devia-
tion value of samples from ﬁve experiments in diﬀerent groups
consisting of ﬁve mice.
IL-6 release from mice macrophages exposed to diﬀerent
venoms [18, 19, 36, 37].
Various studies have shown that TNF is a key inter-
mediate in the over reaction on the part of the host. TNF
exerts a wide spectrum of biological activities and con-
tributes to the pathophysiology of septic shock. Under the
conditions used in the present study, we observed that
the eﬀect of FII on the macrophage may alter TNF pro-
duction. TNF, IL-1α,a n dI L - 1 β production peaked af-
ter 12 hours, whereas IL-6 peaked after 24 hours. The
decrease of TNF levels after 48 hours has been also ob-
served by other authors [38, 39]. The transient accumu-
lation of TNF could be explained by consumption due to
an autocrine process. The secretion by phagocytizing cells
of proinﬂammatory cytokines accounts for characteris-
tic granuloma formation. Cytokine concentrations were
comparable to those detected after macrophage treatment
with crude TSV. The high levels of TNF produced by
macrophages following exposure to FII may suggest that
this is the main factor responsible for septic shock di-
arrhoea observed in animal models. Together with IL-1,
TNFmayaccountfortheacute-phaseresponsesymptoms
such as fever and lethargy.
Thus these results show that the murine macrophages
treatedwithfractionsarestimulatedtoproducetheproin-
ﬂammatory acute-phase cytokines TNF, IL-1, and IL-6,
but in nontoxic form. Such diﬀerences in the induction of
these proinﬂammatory cytokines by macrophages in re-
sponse to toxic fractions may be an important factor in
the pathogenesis induced by this venom.
IFN-γ is a key cytokine in host defences against intra-
cellular organisms and enhances the ability of peritoneal
macrophages and Kupﬀer cells for phagocytosis [40, 41].
These authors in [40, 41] indicated that the IFN-γ may
exert and participate in both beneﬁcial and detrimen-
tal eﬀects. The present study shows that TSV(—) and
its fractions are capable of stimulating murine peritoneal
macrophages to release IFN-γ. Cytokines are potent pow-
erful modulators of murine macrophage reactive oxygen
intermediates such as H2O2 and reactive nitrogen inter-
mediates such as NO.
The hypothesis that the TSV is capable of exerting ac-
tion on macrophages was formulated by Petricevich [18].
The present study describes an experimental model de-
signed to test the hypothesis that the fraction(s) obtained
from venom could be responsible for macrophage ac-
tivation. To examine this possibility, the preestablished
doses of TSV(—) and its fractions were added to cultured
macrophages, and the activation of these cells was deter-
mined. Diﬀerent amounts of TSV(—) and/or fractions
were used for this study (data not shown) which were ca-
pable of activating macrophages for the release of H2O2.
In macrophages, NO and other reactive nitrogen in-
termediates are derived from L-arginine via an enzymatic
pathway controlled by an inducible NO synthase (iNOS)
[42], and their synthesis is modulated by cytokines. While
TNF and IFN-γ are potent activators of iNOS, IL4 and
IL-10 suppress it [43, 44, 45]. NO is known to be in-
volved in multiple biologically important reactions. The
eﬀects of NO on the inﬂammatory response depends on
the concentration. Low levels of NO appear to be anti-
inﬂammatory, while higher levels such as those produced
in response to bacterial lipopolysaccharide can be proin-
ﬂammatory [46]. In this study, we described the fact that
TSV(—) and/or fractions FII and FIII from venom have
the ability to stimulate macrophages to produce NO and
m a ye x e r tam o d u l a t o r ye ﬀect on NO levels and thus on
the host inﬂammatory response. This may result in the
developmentofsymptomaticorasymptomaticinjections,
depending on the relative activities.
The eﬀects of TSV(—) and fractions on H2O2 and
NOproductionwerecomparedwiththosecausedbyIFN-
γ stimulation. Peritoneal macrophages stimulated with
TSV(—) and fractions FI, FIII, FIV, and FV, fail to pro-
duce TNF either alone or in combination with IFN-γ
a sac o s t i m u l u s .T h el e v e l so fH 2O2 were modest and
increased for groups of macrophages stimulated with
TSV(—) and/or FII or FIII combined with IFN-γ.I n
contrast, in groups of peritoneal macrophages stimulated
with FII combined with IFN-γ, a signiﬁcant increase in
levels of NO was observed. These results suggest that one48 V. L. Petricevich and I. Lebrun 2005:1 (2005)
compoundorasynergismofseveralTSV(—)constituents
presented immunomodulatory activity through the ac-
tivation of macrophage function with consequent oxy-
gen.
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